Related Experiment Video
Updated: Aug 1, 2025

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
Published on: June 25, 2014
Cordycepin protects islet β-cells against glucotoxicity and lipotoxicity via modulating related proteins of ROS/JNK
Baiyi Yan1, Yanchun Gong1, Wei Meng2
1School of Life Science, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi 330013, PR China.
Abstract:
Type 2 diabetes mellitus (T2DM) is a common and multiple endocrine metabolic disease. When pancreatic β cell in case of dysfunction, the synthesis and secretion of insulin are reduced. This study is to explore the effect of cordycepin (the molecular formula C10H13N5O3), a natural adenosine isolated from Cordyceps militaris, on high glucose/lipid-induced glucotoxicity and lipotoxicity in INS-1 cells. Our results showed that cordycepin improved cell viability, improved cell energy metabolism and promoted insulin synthesis and secretion. The mechanism may be related to that cordycepin reduces intracellular reactive oxygen species (ROS), increases ATP content in cells, causes membrane depolarization and balances the steady state of Ca2+ concentration, cordycepin inhibits cell apoptosis, which may be related to the downregulation of proteins level of c-Jun N-terminal kinases (JNK) phosphorylation, cytochrome c (Cyt-c), Cleaved Capase-3, the mRNA level of JNK, Cyt-c, Capase-3 and upregulation of proteins/mRNA level of pancreatic and duodenal homeobox factor-1 (PDX-1). These results suggest that cordycepin can inhibit cell apoptosis and protect cell number by downregulating ROS/JNK mitochondrial apoptosis pathway under high glucose/lipid environment, thereby improving the function of pancreatic islet cells, providing a theoretical basis for the related research on the prevention and control of cordycepin on T2DM.
Insights
Cordycepin, a compound from Cordyceps militaris, protects pancreatic islet cells from high glucose/lipid damage. This natural compound improves insulin secretion and cell survival, offering potential for type 2 diabetes mellitus treatment.
Area of Science:
- Endocrinology
- Molecular Biology
- Pharmacology
Background:
- Type 2 diabetes mellitus (T2DM) involves pancreatic beta cell dysfunction, reducing insulin synthesis and secretion.
- Glucotoxicity and lipotoxicity exacerbate beta cell dysfunction in T2DM.
Purpose of the Study:
- To investigate the protective effects of cordycepin against high glucose/lipid-induced toxicity in INS-1 pancreatic beta cells.
- To elucidate the underlying molecular mechanisms of cordycepin's action.
Main Methods:
- INS-1 cells were exposed to high glucose and lipid conditions.
- Cordycepin treatment was applied to assess its impact on cell viability, energy metabolism, and insulin secretion.
- Mechanisms involving reactive oxygen species (ROS), ATP levels, calcium (Ca2+) concentration, and apoptosis pathways (JNK, cytochrome c, Caspase-3) were analyzed.
Main Results:
- Cordycepin enhanced INS-1 cell viability and energy metabolism.
- It promoted insulin synthesis and secretion.
- Cordycepin reduced intracellular ROS, increased ATP, stabilized cell membrane potential and Ca2+ levels.
- It inhibited apoptosis by downregulating the ROS/JNK mitochondrial pathway and upregulating PDX-1.
Conclusions:
- Cordycepin protects pancreatic islet cells from glucotoxicity and lipotoxicity by inhibiting apoptosis via the ROS/JNK pathway.
- It improves pancreatic islet cell function, suggesting potential therapeutic applications for T2DM.
Related Concept Videos
Cell Specific Gene Expression
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Insulin: The Receptor and Signaling Pathways
Insulin Secretory Vesicles
Dipeptidyl Peptidase 4 Inhibitors
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...

